Alcaftadine

CAS No. 147084-10-4

Alcaftadine( R-89674 )

Catalog No. M12016 CAS No. 147084-10-4

A H1 histamine receptor antagonist that used for prevention of allergic conjunctivitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 28 In Stock
25MG 60 In Stock
50MG 91 In Stock
100MG 127 In Stock
200MG 203 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Alcaftadine
  • Note
    Research use only, not for human use.
  • Brief Description
    A H1 histamine receptor antagonist that used for prevention of allergic conjunctivitis.
  • Description
    A H1 histamine receptor antagonist that used for prevention of allergic conjunctivitis.Allergy Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    R-89674
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H1receptor|H2receptor|H4receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    Allergy

Chemical Information

  • CAS Number
    147084-10-4
  • Formula Weight
    307.3895
  • Molecular Formula
    C19H21N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 40 mg/mL
  • SMILES
    O=CC1=CN=C2/C(C3=CC=CC=C3CCN12)=C4CCN(C)CC/4
  • Chemical Name
    5H-Imidazo[2,1-b][3]benzazepine-3-carboxaldehyde, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Linetastine

    Linetastine (TMK-688) is a 5-lipoxygenase inhibitor (5-LOX) that inhibits leukotriene production and antagonizes the effects of histamine.Linetastine is used in studies of asthma, atherosclerosis, and peptic ulcers.

  • JNJ-5207852 dihydroc...

    JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2?nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13?mg?kg?1, subcutaneously.

  • MK-0249

    MK-0249 is a novel potent, selective histamine H3 inverse agonist for the treatment of cognitive impairment with schizophrenia.